Company News
AB Dynamics shares jump as six-month profits double
AB Dynamics nearly doubled its profits over the first half, even as it continued to expand its international footprint and invest for the future.
Thursday preview: US corporate results, BoJ in focus
Around the world, financial markets are likely to remain fixated on the US earnings season, although central banks will not be far from investors' minds.
Sunrise Resources makes progress with various projects
Sunrise Resources updated the market on some of its projects on Wednesday, saying that at the CS Pozzolan-Perlite Project, the latest testwork showed “promise” for the production of premium-value super-coarse horticultural grades of perlite.
PetroNeft confirms new reserves in Cheremshanskoye field
Russia-focussed oil and gas exploration and production company PetroNeft updated the market on its 50%-owned licence 67 on Wednesday, reporting that new reserves had been approved for the licence in the Cheremshanskoye field.
Ixico signs on two new biopharmaceutical clients
Data analytics company Ixico has signed contracts with two biopharmaceutical companies to provide its technology-enabled imaging services to support an early phase study in Huntington's disease (HD), and a phase 3 study in another rare neurological disease.
Diurnal gets orphan drug designation for Alkindi in Australia
Specialty pharmaceutical company Diurnal Group announced on Wednesday that its ‘Alkindi’ product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication ‘replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old’.
Metals Exploration emerges from quarter of change
Pacific Rim-focussed natural resources exploration and development company Metals Exploration updated the market on its Runruno gold project in the Philippines on Wednesday, reporting mining of 2. 93Mt in the quarter ended 31 March, with total ore mined standing at 573Kt.
Beximco gets FDA approval for generic anti-allergy drug
Beximco Pharmaceuticals announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its cyproheptadine hydrochloride tablet 4mg anti-allergy drug, which is a generic equivalent to ‘Periactin’ 4mg tablets from Merck and Company.
Boston Scientific misses first-quarter targets
Shares in Boston Scientific eased on Wednesday after the US medical devices company missed its first-quarter sales targets.
Occidental Petroleum trumps Chevron offer for Anadarko
Occidental Petroleum has offered to buy Anadarko for $76 a share, trumping a $65 a share offer from Chevron earlier this month.
Shell and BP in talks over future of North Sea field - reports
Royal Dutch Shell is to be in talks with rival BP over control of the Shearwater oil and gas field in the North Sea, it has emerged.
Mi-Pay revenue boosted by fraud management launch
Mi-Pay Group's shares edged upwards on Wednesday as the company reported a reduction in annual loss as revenue crept up following the launch of its new fraud management service.
No PG&E buyout in the works, Berkshire Hathaway's Buffett tells CNBC
Berkshire Hathaway has denied reports that it is plotting a takeover of troubled California utility PG&E, which would have marked its return to the M&A trail after a nearly four-year lull.
Petropavlovsk production dips but profits boosted by cost-cutting
Petropavlovsk's shares dipped on Wednesday after the gold miner reported a drop in annual revenues on the back of a decrease in gold sales and production, though results were still ahead of expectations.
Nissan warns on profits for a second time
Shares in Nissan have lost 4% after the Japanese car maker cut its profit guidance for the second time this year.
SAP shares surge as it upgrades 2019 outlook
SAP has increased its full-year outlook and pledged to improve margins following a bumper first quarter, as it emerged that US activist investor Elliot had taken a stake in the German firm.
Deutsche Bank and UBS plot asset management merger
Deutsche Bank and UBS have been discussing for months a possible tie-up between their two asset management arms that would result in the creation of Europe's largest investment firm.
Midatech Pharma mired in losses as R&D costs mount
Midatech Pharma's shares dropped on Wednesday as the company reported an annual loss and falling cash balances, though it remained confident in its ability to create value over the next 18-24 months.
Ascent Resources raises £750,000 in oversubscribed placing
Exploration and production outfit Ascent Resources completed an oversubscribed placing of 214. 2m ordinary shares on Wednesday.
RDI REIT agrees standstill period with Aviva until October
RDI REIT updated the market on the Aviva Shopping Centre facility on Wednesday, reporting that a standstill period had been agreed to 11 October, during which time Aviva confirmed that it would not take any action to accelerate its security under the facility agreement.